ArticleOncogene2018

BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosis.

Ulrike Heinicke et al.PubMed ↗Publisher ↗

No numbers read from the abstract.